Literature DB >> 22026726

Coenzyme A binding to the aminoglycoside acetyltransferase (3)-IIIb increases conformational sampling of antibiotic binding site.

Xiaohu Hu1, Adrianne L Norris, Jerome Baudry, Engin H Serpersu.   

Abstract

NMR spectroscopy experiments and molecular dynamics simulations were performed to describe the dynamic properties of the aminoglycoside acetyltransferase (3)-IIIb (AAC) in its apo and coenzyme A (CoASH) bound forms. The (15)N-(1)H HSQC spectra indicate a partial structural change and coupling of the CoASH binding site with another region in the protein upon the CoASH titration into the apo enzyme. Molecular dynamics simulations indicate a significant structural and dynamic variation of the long loop in the antibiotic binding domain in the form of a relatively slow (250 ns), concerted opening motion in the CoASH-enzyme complex and that binding of the CoASH increases the structural flexibility of the loop, leading to an interchange between several similar equally populated conformations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22026726     DOI: 10.1021/bi201008f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Ligand promiscuity through the eyes of the aminoglycoside N3 acetyltransferase IIa.

Authors:  Adrianne L Norris; Engin H Serpersu
Journal:  Protein Sci       Date:  2013-07       Impact factor: 6.725

2.  Cosubstrate tolerance of the aminoglycoside resistance enzyme Eis from Mycobacterium tuberculosis.

Authors:  Wenjing Chen; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.191

3.  Quantitative proteome profiling of C. burnetii under tetracycline stress conditions.

Authors:  Iosif Vranakis; Pieter-Jan De Bock; Anastasia Papadioti; Yannis Tselentis; Kris Gevaert; Georgios Tsiotis; Anna Psaroulaki
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.